Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-30 19:26:43 - browse：8243

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Illumina names Agilent executive as new CEO

focus

WSS

Doctors' information doesn't help them choose wisely when sick

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

A new House health package & hospitals’ new site

How digital tools helped lower hypertension in marginalized patients

Industry veterans launch new biotech VC with $310M

Vaccine advisory panel ACIP left half staffed by HHS

Wikipedia

Wikipedia

leisure time

Supreme Court strikes down use of affirmative action

Vaccine advisory panel ACIP left half staffed by HHS

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How digital tools helped lower hypertension in marginalized patients

Hepatitis C has a cure — but many Americans still lack access to it

Key House Republican on health care plans exit from Congress

As demand for Covid shots wanes, Moderna seeks its next success

Vaccine advisory panel ACIP left half staffed by HHS

Cancer drug shortages should be causing more outrage

ALS advocates say criticism of new drugs misses bigger picture

hotspot

For Medicare Advantage, Democrats want stronger protections around AI

How to protect patients from sexual assault

Robert F. Kennedy is pitching centrism on health, even on abortion

Snackable artificial intelligence, expert AI, and the pharma industry

Vaccine advisory panel ACIP left half staffed by HHS

Covid hospitalizations on the rise, Humana says

focus

focus

explore

explore